Across Europe, we think structural change is leading to increasingly compelling opportunities for investors.
Moody’s Investors Services recently gave the global pharmaceutical industry a negative outlook for the next 12 to 18 months, in large part due to the patent expirations of major drugs in 2011 and 2012. Some drug companies are already dealing with the effects of patent expiration and are increasing expansion efforts and merger-and-acquisition activity to
Concerns about a sovereign debt crisis in Europe have re-emerged in recent weeks, highlighted by the government of Ireland’s November 21 application for tens of billions of euros in aid from the European Union (EU) and the International Monetary Fund (IMF). This action was taken to address weakness in Ireland’s banking system, which has been
While Germany emerged from Europe’s recent turmoil with accelerating economic growth and strengthening exports, the Eurozone still faces imbalances. Growth accelerated despite debt turmoil For the second quarter, Germany reported a stronger-than-expected expansion of 2.2% — its best quarterly result since 1990, the year of the country’s reunification. It achieved this despite the market turmoil